Cibus, Inc.

NasdaqCM CBUS

Cibus, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD -493.20 M

Cibus, Inc. EBITDA is USD -493.20 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -902.09% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Cibus, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -49.22 M, a -160.26% change year over year.
  • Cibus, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -18.91 M, a 40.65% change year over year.
  • Cibus, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -31.87 M, a 20.71% change year over year.
  • Cibus, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -40.19 M, a -21.64% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
NasdaqCM: CBUS

Cibus, Inc.

CEO Mr. Rory Balfour Riggs M.B.A.
IPO Date July 20, 2017
Location United States
Headquarters 6455 Nancy Ridge Drive
Employees 183
Sector Consumer Staples
Industries
Agriculture Biotechnology Fertilizers
Description

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

StockViz Staff

January 15, 2025

Any question? Send us an email